MediciNova Receives Notice of Patent Allowance for Method of Treating Acute Exacerbations of Asthma

MediciNova Receives Notice of Patent Allowance for Method of Treating Acute Exacerbations of Asthma

[at noodls] – SAN DIEGO, Dec. 9, 2012 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities … more

View todays social media effects on MNOV

View the latest stocks trending across Twitter. Click to view dashboard

See who MediciNova is hiring next, click here to view

Share this post

Comments (0)